• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changing trends in therapy delivery with a third generation noncommitted implantable defibrillator: results of a large single center clinical trial.

作者信息

Luceri R M, Habal S M, David I B, Puchferran R L, Muratore C, Rabinovich R

机构信息

Interventional Cardiac Arrhythmia Center, Holy Cross Hospital, Fort Lauderdale, Florida.

出版信息

Pacing Clin Electrophysiol. 1993 Jan;16(1 Pt 2):159-64. doi: 10.1111/j.1540-8159.1993.tb01554.x.

DOI:10.1111/j.1540-8159.1993.tb01554.x
PMID:7681564
Abstract

Thirty-four patients underwent implantation of a third generation ICD, the 4210 ATP, for sudden cardiac death or ventricular tachycardia. This device incorporates significant telemetry logs as well as a detailed analysis of each arrhythmia episode detected. During the period of clinical follow-up, a mean of 12.2 months, a total of 26,569 VT or VF detections were made. The vast majority of these were either due to atrial fibrillation, nonsustained VT, or "noise" detection, and only 6% led to device therapy. ATP was successful in 86.3% of episodes, with 3.5% accelerations and 2.4% failure of ATP trains. The majority of inappropriate therapy episodes were clustered in seven patients, and all were easily diagnosed with the aid of the extensive telemetry logs and sense histories. Of five late deaths, three were from congestive heart failure, one from cerebrovascular accident, and one unknown. These data reveal that this "tiered" therapy noncommitted ICD performs to expectations; the stored data is of significant value in diagnosing the cause of ICD therapy. In addition, ATP is an effective modality for termination of VT.

摘要

相似文献

1
Changing trends in therapy delivery with a third generation noncommitted implantable defibrillator: results of a large single center clinical trial.
Pacing Clin Electrophysiol. 1993 Jan;16(1 Pt 2):159-64. doi: 10.1111/j.1540-8159.1993.tb01554.x.
2
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
3
Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.新型植入式起搏除颤器所提供的自动多模式设备治疗室性快速心律失常的疗效。一项欧洲多中心研究(涉及102例植入)的结果
Circulation. 1992 Aug;86(2):363-74. doi: 10.1161/01.cir.86.2.363.
4
Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators.
Pacing Clin Electrophysiol. 1995 Jan;18(1 Pt 2):133-6. doi: 10.1111/j.1540-8159.1995.tb02491.x.
5
Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病患者的长期随访。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):750-6. doi: 10.1111/j.1540-8167.2011.02288.x. Epub 2012 Feb 21.
6
Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.多中心心脏再同步治疗自动除颤器植入试验(MADIT-CRT)中室性心律失常或死亡的器械治疗的性别差异
J Cardiovasc Electrophysiol. 2015 Aug;26(8):862-871. doi: 10.1111/jce.12701. Epub 2015 Jun 17.
7
Implantable transvenous cardioverter-defibrillators.植入式经静脉心脏复律除颤器
Circulation. 1993 Apr;87(4):1152-68. doi: 10.1161/01.cir.87.4.1152.
8
Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.心力衰竭与植入式心脏复律除颤器患者的电击风险:室性心律失常触发因素(TOVA)研究结果
Circulation. 2004 Mar 23;109(11):1386-91. doi: 10.1161/01.CIR.0000120703.99433.1E. Epub 2004 Mar 1.
9
Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.经电话传输监测及存储来自植入式心脏复律除颤器的心律失常检测与治疗数据。
Pacing Clin Electrophysiol. 1995 Aug;18(8):1531-9. doi: 10.1111/j.1540-8159.1995.tb06739.x.
10
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者心脏骤停或持续性室性心动过速后的生存率。
J Am Coll Cardiol. 1999 May;33(6):1596-601. doi: 10.1016/s0735-1097(99)00056-x.

引用本文的文献

1
Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review.植入式心脏复律除颤器中的抗心动过速起搏程控:一项系统评价。
World J Cardiol. 2017 May 26;9(5):429-436. doi: 10.4330/wjc.v9.i5.429.
2
A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.一种新型低能量电疗法,当抗心动过速起搏失败时,其终止室性心动过速所需的能量低于双相电击。
J Am Coll Cardiol. 2012 Dec 11;60(23):2393-8. doi: 10.1016/j.jacc.2012.08.1001. Epub 2012 Nov 7.
3
Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest.
植入式心脏复律除颤器治疗无心脏骤停的稳定性室性心动过速患者的益处。
Br Heart J. 1995 Feb;73(2):158-63. doi: 10.1136/hrt.73.2.158.